Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points. Telomerase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback